Liver Cancer Trial, Recruiting (NCT06342414)

Liver Cancer Trial, Recruiting NCT06342414 Sponsor: City of Hope Medical Center Condition: Liver Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06342414 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Liver Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with hepatocellular carcinoma (a type of primary liver cancer) confirmed by a tissue sample analysis
People who have been diagnosed with intrahepatic cholangiocarcinoma (a type of bile duct cancer that starts inside the liver) confirmed by a tissue sample analysis
People who have gone through the standard tests and procedures used to diagnose and determine the stage of their cancer, following local medical guidelines
People who have had at least one blood sample taken before starting any treatment aimed at curing their cancer

Who may not be able to join:

People who are unable or unwilling to give formal consent to take part in the trial
People who have both hepatocellular carcinoma and intrahepatic cholangiocarcinoma at the same time
People whose primary liver cancer is a type other than hepatocellular carcinoma or intrahepatic cholangiocarcinoma
People whose cancer in the liver has spread there from another part of the body (secondary or metastatic liver cancer)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ajay Goel, PhD, City of Hope Medical Center

Phone: 6262183452

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06342414

Sponsor: City of Hope Medical Center

Phase: Not Applicable

Status: Recruiting

Condition: Liver Cancer

Trial contact: 6262183452

More information: https://clinicaltrials.gov/study/NCT06342414

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with hepatocellular carcinoma (a type of primary liver cancer) confirmed by a tissue sample analysis
People who have been diagnosed with intrahepatic cholangiocarcinoma (a type of bile duct cancer that starts inside the liver) confirmed by a tissue sample analysis
People who have gone through the standard tests and procedures used to diagnose and determine the stage of their cancer, following local medical guidelines
People who have had at least one blood sample taken before starting any treatment aimed at curing their cancer

Who may not be able to join:

People who are unable or unwilling to give formal consent to take part in the trial
People who have both hepatocellular carcinoma and intrahepatic cholangiocarcinoma at the same time
People whose primary liver cancer is a type other than hepatocellular carcinoma or intrahepatic cholangiocarcinoma
People whose cancer in the liver has spread there from another part of the body (secondary or metastatic liver cancer)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

City of Hope Medical Center

Registry

ClinicalTrials.gov

Start date

15 March 2024

Est. completion

18 June 2028

Where this trial is recruiting

🇯🇵 Japan 🇺🇸 United States

Primary endpoints

Sensitivity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov